Drug profile · INN
bromazepam
LEXOTAN
bromazepam (LEXOTAN) is a gaba receptor alpha-2 subunit positive allosteric modulator. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bromazepam
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
bromazepam (LEXOTAN) is a gaba receptor alpha-2 subunit positive allosteric modulator. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN bromazepam
Brand LEXOTAN
Mechanism GABA receptor alpha-2 subunit positive allosteric modulator
Target Gamma-aminobutyric acid receptor subunit alpha-2
Originator Lacuna Pharma Pty Ltd
Mechanism of action
GABA receptor alpha-2 subunit positive allosteric modulator
Primary target: Gamma-aminobutyric acid receptor subunit alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is bromazepam?
bromazepam (LEXOTAN) is a gaba receptor alpha-2 subunit positive allosteric modulator. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for bromazepam?
LEXOTAN is a marketed brand name for bromazepam. Check FDA Drugs@FDA for the current US label holder and prescribing information.